Instrument Inactif

Autres langues CM Life Sciences III Inc. Nasdaq

Actions

CMLTU

US1258412055

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

CM Life Sciences III : UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION - Form 8-K	20/12/21
Drug Firm EQRx to Make Nasdaq Debut Monday After Merger Deal With Blank Check Company	17/12/21
CM Life Sciences III : Submission of Matters to a Vote of Security Holders - Form 8-K	17/12/21
CM LIFE SCIENCES III INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	17/12/21
CM Life Sciences III Inc.(NasdaqCM:CMLT) dropped from NASDAQ Composite Index	17/12/21
EQRx, Inc. completed the acquisition of CM Life Sciences III Inc. from CMLS Holdings III LLC and others in a reverse merger transaction.	17/12/21
EQRx and CM Life Sciences III Announce Effectiveness of Form S-4 Registration Statement and Stockholder Meeting Details to Vote on Proposed Business Combination	02/12/21
EQRx, Inc. and CM Life Sciences III Announce Effectiveness of Form S-4 Registration Statement and Stockholder Meeting Details to Vote on Proposed Business Combination	02/12/21
EQRx to Present at the 4th Annual Evercore ISI HealthCONx Conference	29/11/21
CM LIFE SCIENCES III INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q/A)	23/11/21
CM LIFE SCIENCES III INC. : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)	23/11/21
EQRx Announces Partnership Agreement with Abdul Latif Jameel Health to Commercialize Lead Oncology Programs in Middle East, Turkey and Africa	22/11/21
EQRx Launches “Remaking Medicine: On The Record” Investor Video Series	16/11/21
CM LIFE SCIENCES III INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	15/11/21
CM LIFE SCIENCES III INC. : Entry into a Material Definitive Agreement (form 8-K)	29/10/21
CM Life Sciences III : EQRx to Collaborate With England's National Health Service Over Cheaper Cancer Medicines	19/10/21
EQRx : and NHSE Sign Memorandum of Understanding to Enter into England’s First Population Health Partnership for Cancer Drugs	19/10/21
Certain Class B Common Stock of CM Life Sciences III Inc. are subject to a Lock-Up Agreement Ending on 4-OCT-2021.	04/10/21
EQRx : Appoints Kathy Giusti to Board of Directors	27/09/21
EQRx : Announces Presentation of Phase 3 Data Demonstrating a Progression-Free Survival Benefit with Sugemalimab Consolidation Therapy in Patients with Stage III NSCLC at ESMO Congress 2021	17/09/21

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues CM Life Sciences III Inc. Nasdaq

Actions

CMLTU

US1258412055

Autres langues

Filtres